Ossiam raised its stake in Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 22.3% in the 3rd quarter, HoldingsChannel reports. The firm owned 55,378 shares of the semiconductor company’s stock after acquiring an additional 10,084 shares during the quarter. Ossiam’s holdings in Synopsys were worth $27,323,000 as of its most recent SEC filing.
Several other institutional investors have also recently made changes to their positions in SNPS. Lionshead Wealth Management LLC increased its position in Synopsys by 1.9% during the second quarter. Lionshead Wealth Management LLC now owns 914 shares of the semiconductor company’s stock valued at $469,000 after acquiring an additional 17 shares during the last quarter. YANKCOM Partnership boosted its position in Synopsys by 3.3% in the second quarter. YANKCOM Partnership now owns 537 shares of the semiconductor company’s stock worth $275,000 after purchasing an additional 17 shares during the last quarter. Manchester Capital Management LLC grew its stake in shares of Synopsys by 5.3% during the 2nd quarter. Manchester Capital Management LLC now owns 340 shares of the semiconductor company’s stock valued at $174,000 after purchasing an additional 17 shares during the period. Advisors Capital Management LLC grew its stake in shares of Synopsys by 2.3% during the 2nd quarter. Advisors Capital Management LLC now owns 862 shares of the semiconductor company’s stock valued at $442,000 after purchasing an additional 19 shares during the period. Finally, Rothschild Investment LLC increased its position in shares of Synopsys by 15.9% during the 2nd quarter. Rothschild Investment LLC now owns 153 shares of the semiconductor company’s stock valued at $78,000 after purchasing an additional 21 shares during the last quarter. Institutional investors and hedge funds own 85.47% of the company’s stock.
Synopsys Stock Performance
Shares of NASDAQ SNPS opened at $412.63 on Friday. The stock has a market cap of $79.04 billion, a PE ratio of 64.07, a price-to-earnings-growth ratio of 3.41 and a beta of 1.15. Synopsys, Inc. has a 1 year low of $365.74 and a 1 year high of $651.73. The firm has a fifty day moving average price of $461.93 and a 200-day moving average price of $464.57. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.36 and a quick ratio of 1.26.
Insider Activity
In related news, insider Janet Lee sold 250 shares of the stock in a transaction dated Monday, January 12th. The stock was sold at an average price of $530.00, for a total transaction of $132,500.00. Following the completion of the sale, the insider owned 11,959 shares in the company, valued at approximately $6,338,270. This trade represents a 2.05% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CFO Shelagh Glaser sold 3,657 shares of Synopsys stock in a transaction that occurred on Friday, December 19th. The shares were sold at an average price of $460.77, for a total value of $1,685,035.89. Following the sale, the chief financial officer directly owned 17,842 shares in the company, valued at $8,221,058.34. This trade represents a 17.01% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 4,157 shares of company stock worth $1,945,036 over the last 90 days. Company insiders own 0.56% of the company’s stock.
Wall Street Analysts Forecast Growth
Several equities analysts have recently weighed in on SNPS shares. HSBC cut shares of Synopsys from a “buy” rating to a “hold” rating and set a $455.00 price objective on the stock. in a research note on Friday, February 20th. Wells Fargo & Company reduced their target price on shares of Synopsys from $500.00 to $450.00 and set an “equal weight” rating for the company in a report on Thursday, February 26th. Rosenblatt Securities decreased their price target on shares of Synopsys from $560.00 to $530.00 and set a “buy” rating on the stock in a research report on Thursday, February 26th. JPMorgan Chase & Co. lifted their price target on shares of Synopsys from $600.00 to $650.00 and gave the stock an “overweight” rating in a research note on Thursday, December 11th. Finally, Piper Sandler cut their price objective on shares of Synopsys from $520.00 to $430.00 and set a “neutral” rating for the company in a research report on Thursday, February 26th. Eight equities research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and an average target price of $531.00.
Read Our Latest Research Report on SNPS
About Synopsys
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Further Reading
- Five stocks we like better than Synopsys
- A personal warning from Martin Weiss (Please read)
- SpaceX IPO Confirmed: Claim Your Stake Today
- Forget oil — this changes everything about American energy…
- $30 stock to buy before Starlink goes public (WATCH NOW!)
- This coin has everything going for it
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
